(Q44442445)
Statements
A phase II study of docetaxel-irinotecan combination in advanced pancreatic cancer (English)
Jean-Emmanuel Kurtz
Sylvie Négrier
Fares Husseini
Jean-Marc Limacher
Jean-Philippe Wagner
Gilles Prévot
Jean-Pierre Bergerat